The initial study on imaging characteristics and role of 18FDG-PET/CT in pre-treatment colorectal cancer staging

Lê Xuân Thắng, Nguyễn Kim Lưu, Ngô Văn Đàn, Nguyễn Việt Dũng, Trần Thị Thùy Linh, Nguyễn Thị Vân Anh

Main Article Content

Abstract

Objectives: To evaluate the imaging characteristics and the role of 18FDG-PET/CT in pre-treatment colorectal cancer staging.
Subjects and methods: Study on 39 colorectal cancer patients without specific treatment who had taken 18FDG-PET/CT for staging diagnosis, at the Department of Nuclear Medicine, Imaging Center of Military Hospital 103, from February 2017 to November 2020.
Results: The average age was 62.77 ± 14.07. The ability to detect primary tumor lesions in the colorectal of 18FDG-PET/CT was 97.44%.
The majority of patients had rectal tumors, the tumor size was mainly in the range of 5-10 cm and the T3 stage accounted for the most proportion with
60.5%. There was 46.2% of patients had regional lymph node metastasis, in which the group of lymph nodes over 10 mm and the N2 group accounted for a lower proportion, but the mean SUVmax was statistically significantly higher than others group. Distant metastasis was occured mainly in liver, lung-pleural and bone. There were 59.0% patients in stage III and IV. Diagnosis by 18FDG-PET/CT was accurately at 80.77% for T stage and 66.67% for N stage. The sensitivity and specificity, positive predictive value and negative predictive value of 18FDG-PET/CT in the diagnosis of regional lymph node metastasis were 100% and 60%; 55.55% and 100%.

Article Details

References

1. UICC. Global cancer data: GLOBOCAN 2018.
2. Vũ Huy Nùng (2010), “Ung thư trực tràng”, Bệnh học ngoại khoa bụng- Giáo trình đại học, Nhà xuất bản quân đội nhân dân, Hà Nội, 131-135.
3. Bộ y tế (2014), “Hướng dẫn quy trình kỹ thuật khám bệnh, chữa bệnh chuyên ngành Y học hạt nhân”, 246-250.
4. AJCC Cancer Staging Manual (2018), Eighth Edition, 123-127.
5. Koo H.Y. et al (2013), “Investigation of clinical manifestations in korean colorectal cancer patients”. Ann Coloproctol, 4, 29, 139-43.
6. Mainenti PP, Iodice D et al (2011), “Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loc-regional staging”, World J Gastroenterol, 2011 Mar 21; 17 (11): 1427-33.
7. Lê Ngọc Hà (2015), “Nghiên cứu ứng dụng PET/CT sử dụng 18FDG trong bệnh nhồi máu cơ tim, ung thư hạch và ung thư đại trực tràng”, Bệnh viện TW Quân đội 108, 101-112.
8. Mai Trọng Khoa, Phạm Cẩm Phương và cs (2013), “Nghiên cứu giá trị của PET/CT trong chẩn đoán giai đoan bệnh ung thư đại trực tràng trước điều trị”, Tạp chí y học thực hành (857), số 1/2013, Bộ y tế xuất bản, 7-11.
9. Bùi Thị Hoài Thu, Vũ Thị Nhung, Phạm Cẩm Phương (2017), “Đánh giá vai trò của PET/CT trong chẩn đoán ung thư đại trực tràng”, Bệnh viện Bạch Mai.
10. Ozis et al (2014). “The role of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in the primary staging of rectal cancer”, World Journal of Surgical Oncology.
11. Tateishi et al (2007), “Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer”. Eur J Nucl Med Mol Imaging; 34: 1627-1634.
12. Veit-Haibach P. và cs (2009), “Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography”. JAMA; 296 (21), 2590-2600.